Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR Based Method As a Diagnostic Biomarker for Non-Small Cell Lung Cancer.
Xiaoxia Chen,Fei Zhou,Xuefei Li,Guohua Yang,Ling Zhang,Shengxiang Ren,Chao Zhao,Qin-fang Deng,Wei Li,Guanghui Gao,Aiwu Li,Caicun Zhou
DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.11032
IF: 45.3
2015-01-01
Journal of Clinical Oncology
Abstract:11032 Background: To investigate the diagnostic performance of folate receptor (FR) positive circulating tumor cells (CTCs) in distinguishing non-small cell lung cancer (NSCLC) from lung benign disease by using a novel ligand-targeted polymerase chain reaction (LT-PCR) detection technique. Methods: CTCs were enriched from 3ml peripheral blood by immune-magnetic depletion of leukocytes and then labeled with a conjugate of a tumor-specific ligand folic acid and a synthesized oligonucleotide. After washing off free conjugates, the stripped bound conjugates were analyzed by quantitative PCR. Results: 756 participants (473 patients with NSCLC, 227 patients with lung benign disease, and 56 healthy donors) were randomly assigned to a training set and a test set. The CTC levels in patients with NSCLC were significant higher than those with lung benign disease (P < 0.001) and healthy donors (P < 0.001). Compared with CEA, NSE, and Cyfra21-1, CTCs displayed the highest area under curve (AUC) (training set: 0.815; validation set: 0.813) in the diagnosis of NSCLC, with a markedly sensitivity (training set: 72.46%; validation set: 76.37%) and specificity (training set: 88.65%; validation set: 82.39%). The model combining CTCs with CEA, NSE, and Cyfra21-1 was more effective for the diagnosis of NSCLC than tumor makers alone (sensitivity and specificity in the training set: 84.21%, 83.91%; validation set: 88.78%, 87.36%). In addition, the CTC levels were higher in patients with stage III/IV NSCLC compared with those with stage I/II disease. Conclusions: LT-PCR technique was feasible and reliable for detecting FR-positive CTCs in NSCLC patients and CTC levels could be used as a useful biomarker for the diagnosis of NSCLC.